Clinical trial site operations consulting

Improve the work between protocol and performance.

Merindale works alongside research teams on defined site-level problems where experienced operational review can shorten the distance between what a study requires and what the team can reliably execute.

Clinical trial site performance diagnostic

A structured review of a study or research workflow that is open but not performing as expected. We trace the issue through feasibility, start-up, staffing, enrollment, monitoring follow-up, data flow, and day-to-day ownership instead of assuming the visible symptom is the root cause.

Best fit: a trial that is delayed, under-enrolling, carrying repeat findings, or consuming more team effort than expected.

Typical output: a constraint map, prioritized findings, practical actions, owners, and measures that show whether the change is working.

Read: 7 clinical trial handoffs that quietly slow studies →

Study start-up & site activation readiness

Strengthen the site-side work that determines whether a study starts cleanly: protocol feasibility, activation planning, regulatory handoffs, budget and contract coordination, essential-document readiness, internal dependencies, training, and team ownership.

Best fit: sites or research programs where activation dates drift, status is fragmented across teams, or the same startup bottlenecks repeat from study to study.

Typical output: feasibility decision framework, readiness checklist, dependency map, activation tracker, critical-path view, and escalation rhythm.

Explore study start-up & site activation consulting →
Read the site feasibility guide →

Clinical trial enrollment & participant pathway

Break patient enrollment into transitions a site can manage: identification, prescreening, eligibility, approach, consent, scheduling, and follow-through. Then locate where eligible participants are actually being lost before adding more recruitment activity.

Best fit: studies that are open but below target, sites that cannot explain screen failure or approach rates, or programs where clinic-to-research handoffs are inconsistent.

Typical output: participant-pathway map, screening measures, loss-point analysis, ownership model, and targeted workflow changes.

Explore clinical trial enrollment consulting →
Read the GU screening and enrollment guide →

Monitoring, CAPA, quality & inspection readiness

Review site practices around monitoring findings, CAPA decisions and closure, eTMF organization, delegation controls, safety and protocol-deviation workflows, training evidence, and documentation completeness before pressure exposes the gaps.

Best fit: portfolios with aging monitoring actions, repeat findings, inconsistent CAPA follow-up, inspection anxiety, or limited visibility across studies.

Typical output: monitoring action log design, remediation priorities, ownership and escalation model, quality-control checks, and a sustainable review rhythm.

Explore monitoring, CAPA & inspection readiness consulting →
Read the monitoring follow-up and CAPA guide →

Clinical research portfolio operations & team systems

Clarify ownership across a portfolio, improve coordinator workflows, build operating rhythms, and strengthen training and escalation paths for teams carrying multiple complex studies.

Best fit: research programs where individual studies are manageable but the combined portfolio creates workload surprises, inconsistent priorities, or limited leadership visibility.

Typical output: role map, workload and review rhythm, training priorities, exception dashboard, escalation path, and repeatable operating procedures.

Read: how site workflow handoffs create hidden waiting time →

Research data & study workflow

Support site-side data capture and study workflow design, including CRF-to-EDC requirements, patient-reported outcomes, observational databases, specimen and data coordination, query workflow, and process handoffs.

Best fit: studies where duplicate entry, unclear data ownership, repeated queries, manual tracking, or handoffs between source, EDC, CTMS, and local systems create unnecessary work.

Typical output: workflow specification, data-capture requirements, ownership matrix, turnaround expectations, and quality checkpoints.

Read: the clinical trial workflow handoffs worth mapping first →

How we scope the work

Start with the constraint, not a consulting package.

A research team usually does not need another broad transformation program. It needs one operating problem understood well enough to change: a slow activation path, weak feasibility assumptions, an enrollment loss point, monitoring actions that will not close, or a portfolio with unclear ownership.

We work with the people closest to that problem, review the evidence already available, and scope the smallest useful engagement around the constraint. The goal is not to take over the process. It is to help the team see it more clearly and run it more reliably.

See the Diagnose → Redesign → Transfer approach →

Service architecture

Depth where buyers need it. Restraint where they do not.

Three service areas have dedicated pages because they represent distinct operating problems with distinct buyer intent: study start-up and activation, enrollment and participant pathway, and monitoring/CAPA/inspection readiness.

The broader diagnostic, portfolio operations, and data-workflow capabilities remain here rather than being split into thin pages. We will only expand them when client demand, case evidence, and useful content justify a genuinely distinct destination.

Read our professional standards →

Tell us what is delayed, underperforming, or hard to control.

You do not need to select a service first. We will listen to the problem, review what you already know, and scope the smallest useful engagement if there is a genuine fit.